Mevalonate pathway regulates double-negative regulatory T cell stability in metabolic dysfunction–associated steatotic liver disease
Science Advances · 06.11.2026 · 12 (45)
DOI: 10.1126/sciadv.aeb8568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von Hua Jin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Hauptthemen laut MEDLINE: Mevalonic Acid, T-Lymphocytes, Regulatory, Fatty Liver. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Chinese Institutes for Medical Research Beijing.
Abstract (Originalsprache)
Lipid metabolism dysfunction and immune imbalance are critical pathogenic drivers of metabolic dysfunction–associated steatotic liver disease (MASLD). Double-negative regulatory T cells (DNTreg) are important immune regulatory cells that maintain liver immune homeostasis. However, their survival and function are compromised in MASLD. Herein, we found that mevalonate pathway and its rate-limiting enzyme HMG-CoA reductase (HMGCR) were significantly down-regulated in DNTreg from both mice and patients with MASLD, correlating with impaired DNTreg viability and immunosuppressive function. Arachidonic acid is enriched in MASLD liver and inhibits DNTreg HMGCR expression. Geranylgeranyl pyrophosphate (GGPP), a downstream product of HMGCR, mediates RAC1 geranylgeranylation, which facilitates its interaction with mitochondrial CLPX protease, thereby enhancing mitochondrial function and immunoregulatory activity of DNTreg. Adoptive transfer of Pggt1b +/− DNTreg into MASLD mice demonstrated significantly diminished therapeutic efficacy compared with wild-type DNTreg. In conclusion, mevalonate metabolism–mediated geranylgeranylation is essential for the suppressive activity and immune homeostasis of DNTreg in MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
- Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
- Immunology Research Center for Oral and Systemic Health, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
- General Surgery Department, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
- Beijing Laboratory of Oral Health, Capital Medical University School of Basic Medicine, Beijing 100069, China.
- Department of General Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
ORCID-Profile: Hua Jin, Xiyu Wang, Xiaotong Han, Guangyong Sun, Dong Zhang
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Chinese Institutes for Medical Research Beijing
- Beijing Municipal Administration of Hospitals Ascent Plan
- Youth Beijing Scholar
- Reform and Development Program of Beijing Institute of Respiratory Medicine Grant
Zitieren
APA
Jin, H., Wang, X., Zhou, L., Zhong, X., Wei, Y., Han, X., Xu, N., Fang, P., Zhang, Z., Du, X., Li, M., Wang, S., Zhang, Z., Sun, G., & Zhang, D. (2026). Mevalonate pathway regulates double-negative regulatory T cell stability in metabolic dysfunction–associated steatotic liver disease. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aeb8568
Vancouver
Jin H, Wang X, Zhou L, Zhong X, Wei Y, Han X, et al. Mevalonate pathway regulates double-negative regulatory T cell stability in metabolic dysfunction–associated steatotic liver disease. Science Advances. 2026;12(45). doi:10.1126/sciadv.aeb8568
BibTeX
@article{Jin2026,
author = {Jin, Hua and Wang, Xiyu and Zhou, Longyang and Zhong, Xinjie and Wei, Yunxiong and Han, Xiaotong and Xu, Nan and Fang, Peiyang and Zhang, Zihan and Du, Xiaonan and Li, Mengyi and Wang, Songlin and Zhang, Zhongtao and Sun, Guangyong and Zhang, Dong},
title = {Mevalonate pathway regulates double-negative regulatory T cell stability in metabolic dysfunction–associated steatotic liver disease},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {45},
doi = {10.1126/sciadv.aeb8568}
}
EUVIMED